The Trump administration’s crackdown on pharmaceutical ads is a welcome step toward lessening Big Pharma’s influence over conversations between patients and their doctors.

Americans are among the few people in the world bombarded with advertisements for medications most of us don’t need — New Zealand is the only other country that allows direct-to-consumer drug advertising. These policies have given pharmaceutical companies significant influence over consumer behavior on health.

The executive order signed by President Donald Trump recently is an attempt to force these companies to be more transparent about the side effects of their products — and hopefully draw necessary attention to the increasingly insidious ways the industry reaches consumers. But the order is meaningless without toug

See Full Page